Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Pucci

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biological Chemistry|April 4, 2002
Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic systemGabriella Fibbi, Silvia D'Alessio, Marco Pucci, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
The plasminogen activation system in inflammationMario Del Rosso, Gabriella Fibbi, Marco Pucci, et al.
Clinical & Experimental Metastasis|June 18, 2002
Multiple pathways of cell invasion are regulated by multiple families of serine proteasesMario Del Rosso, Gabriella Fibbi, Marco Pucci, et al.
European Journal of Oral Sciences|December 23, 2006
Plasminogen activators and inhibitor type-1 in alveolar osteitisSimona Serratì, Francesca Margheri, Silvia Bruschi, et al.
Biochemical Pharmacology|December 2, 2008
TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesisSimona Serratì, Francesca Margheri, Marco Pucci, et al.
International Journal of Oncology|June 9, 2005
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat proteinFrancesca Margheri, Silvia D'Alessio, Simona Serratì, et al.
Arthritis and Rheumatism|November 30, 2006
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cellsFrancesca Margheri, Mirko Manetti, Simona Serratì, et al.
International Journal of Cancer|April 1, 2004
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in miceSilvia D'Alessio, Francesca Margheri, Marco Pucci, et al.
Neoplasia (New York, N.Y.)|October 2, 2009
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in miceFrancesca Margheri, Simona Serratì, Andrea Lapucci, et al.
Arthritis and Rheumatism|October 12, 2004
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesisSilvia D'Alessio, Gabriella Fibbi, Marina Cinelli, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biological Chemistry|April 4, 2002
Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic systemGabriella Fibbi, Silvia D'Alessio, Marco Pucci, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
The plasminogen activation system in inflammationMario Del Rosso, Gabriella Fibbi, Marco Pucci, et al.
Clinical & Experimental Metastasis|June 18, 2002
Multiple pathways of cell invasion are regulated by multiple families of serine proteasesMario Del Rosso, Gabriella Fibbi, Marco Pucci, et al.
European Journal of Oral Sciences|December 23, 2006
Plasminogen activators and inhibitor type-1 in alveolar osteitisSimona Serratì, Francesca Margheri, Silvia Bruschi, et al.
Biochemical Pharmacology|December 2, 2008
TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesisSimona Serratì, Francesca Margheri, Marco Pucci, et al.
International Journal of Oncology|June 9, 2005
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat proteinFrancesca Margheri, Silvia D'Alessio, Simona Serratì, et al.
Arthritis and Rheumatism|November 30, 2006
Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cellsFrancesca Margheri, Mirko Manetti, Simona Serratì, et al.
International Journal of Cancer|April 1, 2004
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in miceSilvia D'Alessio, Francesca Margheri, Marco Pucci, et al.
Neoplasia (New York, N.Y.)|October 2, 2009
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in miceFrancesca Margheri, Simona Serratì, Andrea Lapucci, et al.
Arthritis and Rheumatism|October 12, 2004
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesisSilvia D'Alessio, Gabriella Fibbi, Marina Cinelli, et al.
Pageof 1